Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global synthetic biology market is expected to grow at a CAGR of 25% during 2022-2027.
Synthetic biology is a new interdisciplinary field that includes the application of engineering principles to biology. It intends to design and manufacture biological components and systems that do not yet exist in nature. Synthetic biology combines the chemical synthesis of DNA with increased knowledge of genetics to enable researchers to quickly create cataloged DNA sequences and assemble them into new genomes. With the improved speed and cost of DNA synthesis, scientists can use advanced biofuels, bioproducts, renewable chemicals, bio-based specialty chemicals, pharmaceutical intermediates, fine chemicals, and food ingredients.
Industrial biotechnology provides tools to improve the natural mechanisms of biological processes for the efficient production of enzymes, chemicals, polymers, and even daily necessities such as foods and fuels. Scientists have studied the genomes of microorganisms to identify biological processes that can replace chemical reactions, create new products, make manufacturing processes cleaner, and reduce the number of manufacturing steps.
Industrial biotechnology innovations are now successfully competing and replacing traditional petrochemical manufacturing processes. Companies using synthetic biology believe that they can reduce costs, reduce pollution and carbon dioxide emissions, and increase profitability.
The various approaches that synthetic biology encompasses, such as the design of gene and protein circuits from standard biological parts, the development of synthetic genetic codes, and the creation of artificial cells and organisms, will undoubtedly allow for the application of knowledge in different branches of science and technology.
Redesigning the existing biological parts expands the set of functions for biological processes. Synthetic biology can allow new perspectives and the creation of new biological innovations. Development of technology platforms or creating new or upgraded physical structures can be used to implement new functions and reap benefits.
The following factors will drive the global synthetic biology market growth:
- Synthetic Biology Market Witnessing Significant Rise in Investments
- Increasing Strategic Collaborations & Acquisitions, Developing Multifunctional Products
- Synthetic Biology Bringing Transformative Technologies to Agriculture
Synthetic biology brings a paradigm shift in the field of biomedicine
Synthetic Biology offers modern approaches for engineering new biological systems or redesigning existing ones for practical purposes. CAR-T therapy has some crucial advantages that may not be available with other drugs used for cancer treatment.
The synthetic biology market is witnessing a significant rise in investments.
There is a massive inflow of investments for synthetic biology start-ups as they provide innovative market solutions. There are various pipeline products for the same. Some markets like Germany, China, and Italy are progressing toward a mature markets. In contrast, some regions like Africa do not have a significant number of companies or academic institutes for the same. In contrast, countries like India are in the nascent stages of synthetic biology. There are more opportunities in synthetic biology than challenges in the current scenario. Still, some ethical issues need to be addressed.
Synthetic biology products are transforming the world.
Synthetic biology has the potential to develop real-world applications. Synthetic biology can transform food, source materials, and medicines. Many biotechnologies, pharmaceutical, and agriculture companies best highlight applying synthetic biology tools developed from 2000-to 2021 and are available now or in the coming years. Over the next decade, more products will derive superior performance and affordability from engineering biology. The field is already impacting life sciences & pharmaceuticals, and industrial applications on a large scale.
SEGMENTATION ANALYSIS
Segmentation by Tools
- Oligonucleotides and Synthetic DNA
- Enzymes
- Cloning Technology Kits
- Xeno-Nucleic Acids
- Chassis Organisms
Segmentation by Technology
- Enabling Technology
- Enabled Technology
Segmentation by Application
- Healthcare Application
- Industrial Application
- Food & Agriculture Applications
- Environmental Application
Segmentation by End-user
- Academic/Research Institutes & Laboratories
- Pharma & Biotech Companies
- Others
Key Vendors
- Agilent Technologies
- Codexis
- Eurofins Scientific
- Illumina
- Novozymes
- Thermo Fisher Scientific
Other Prominent Vendors
- Amyris
- ATUM
- Bio-Rad Laboratories
- Creative Biogene
- Creative Enzymes
- Cyrus Biotechnology
- Editas Medicine
- Genomatica
- Genscript
- Ginkgo Bioworks
- Integrated DNA Technologies
- Lucigen
- Moderna
- New England Biolabs
- OriGene Technologies
- Precigen
- Sentebiolab
- SynbiCITE
- Synthego
- Tessera Therapeutics
- Viridos
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
5 Report Assumptions & Caveats
6 Market at a Glance
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Restraints
11 Market Landscape
12 Tools
13 Technology
14 Applications
15 End-User
16 Geography
17 North America
18 Europe
19 Apac
20 Latin America
21 Middle East & Africa
22 Competitive Landscape
23 Key Company Profiles
24 Other Prominent Vendors
25 Report Summary
26 Quantitative Summary
27 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/x9fcss
